News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
All Proposals Approved At Teva Pharmaceutical Industries Limited (TEVA)'s Annual Meeting Of Shareholders 7/31/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2014
Ocular Therapeutix, Inc. (OCUL) To Ring The NASDAQ Stock Market Closing Bell 7/31/2014
Incyte Corporation (INCY) Reports 2014 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs 7/31/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 7/31/2014
Senomyx, Inc. (SNMX) Announces Corporate Update And Second Quarter 2014 Financial Results 7/31/2014
Zealand Pharma  (ZEAL.CO) Reports Increased Lyxumia® Royalty Revenue For H1 2014 And Informs Of Status Update As Provided By Sanofi 7/31/2014
China Cord Blood Corporation Files Its Annual Report On Form 20-F 7/31/2014
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share 7/31/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
Merck & Co., Inc. (MRK): No Tax Inversions, We Just Want Bolt-On Deals 7/30/2014
Gevo, Inc. Announces Proposed Public Offering Of Common Stock And Warrants 7/30/2014
Horizon Pharma To Host Conference Call And Webcast To Discuss Second Quarter 2014 Financial Results On August 7, 2014 7/30/2014
Welcome To The Annual General Meeting Of Shareholders Of Elekta AB (SE:EKTAB) (Publ) 7/30/2014
Tauriga Sciences Inc. (TAUG) Approved To Continue Trading On OTCQB Marketplace 7/30/2014
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Offering Of Common Stock 7/30/2014
QIAGEN N.V. (QGEN) Reports Second Quarter And First Half 2014 Results And Announces Launch Of New $100 Million Share Repurchase Program 7/30/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 7/30/2014
Innophos Holdings, Inc. Declares Dividend Of $0.48 Per Share; Increases Rate By 20% 7/30/2014
Covance Inc. (CVD) Reports Second Quarter Net Revenue Growth Of 8.0% To $639 Million, Pro Forma EPS Growth Of 21.5% To $0.95 And Adjusted Net Orders Of $773 Million 7/30/2014
ContraFect Corporation (CFRXU) To Ring The NASDAQ Stock Market Opening Bell 7/30/2014
Big Pharmas Such As Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pitch In On $51.1 Million Fund For New York City And Seattle Biotechs 7/29/2014
Axxess Pharma, Inc. Announces Audited Financials And S-1 Registration Statement Now Filed With SEC For Up-Listing To Over The Counter Bulletin Board (OTC: BB) Stock Exchange 7/29/2014
SanguiBioTech GmbH Yields Revenues Of Around USD42,000 In Q4 2014 According To Preliminary Figures 7/29/2014
La Jolla Pharmaceutical Company (LJPC) Closes Offering Of Common Stock 7/29/2014
TNI BioTech, Files Definitive Proxy Materials; Mails Letter Urging Shareholders To Vote The Proxy Card 7/28/2014
Derma Sciences, Inc. (DSCI) CEO Discusses Continued Growth Of MEDIHONEY® At Comvita Annual Meeting of Shareholders 7/25/2014
Arena Pharmaceuticals, Inc. (ARNA) To Host Corporate Update And Financial Results Conference Call And Webcast On Friday, August 1 7/25/2014
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend 7/25/2014
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Second Quarter 2014 Financial Results 7/25/2014
Asterias Biotherapeutics Announces Live Investor Webcast 7/25/2014
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs 7/24/2014
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014
Merck & Co., Inc. (MRK) Announces Fourth-Quarter 2014 Dividend 7/24/2014
Charles River Laboratories (Massachusetts) To Webcast Investor Meeting 7/24/2014
CorMedix (CRMD) Granted Extension Of NYSE-MKT Listing 7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014
Sigma-Aldrich Corporation (SIAL) (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted Eps Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted Eps Guidance To A New Range Of $4.32 To $4.40 7/24/2014
Spherix (SPEX) Schedules Shareholder Update Call 7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track 7/24/2014
La Jolla Pharmaceutical Company (LJPC) Announces Proposed Underwritten Offering Of Common Stock 7/23/2014
BioAmber Inc. Announces Exercise In Full Of Underwriters' Option In Connection With Previously Priced Follow-On Offering 7/23/2014
Merge Healthcare (MRGE) Sets Second Quarter 2014 Earnings Call 7/23/2014
Sirona Biochem Announces Shares For Services Agreement 7/23/2014
Neogen Corporation (NEOG) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS 7/22/2014
SAGE Therapeutics Announces Full Exercise Of Over-Allotment Option 7/21/2014
Johnson & Johnson (JNJ) Announces $5 Billion Share Repurchase Program 7/21/2014
IntelGenx Corp. To Host Management Call 7/21/2014
Sirona Biochem - CEO Letter To Shareholders 7/21/2014
Shareholders Support Management Proposals At SYGNIS’ AGM With Overwhelming Majority 7/21/2014
San Diego Biotech Pfenex Inc. Slashes Proposed Range To $8 A Share, Eyes $65 Million In IPO Debut 7/18/2014
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014
Axxess Pharma, Inc. Announces Financial Audits And Form S-1 To Be Filed With SEC Within One Week For Fully Reporting Status 7/18/2014
Vernalis PLC (VNLPY.PK): Notice Of Results For The Six Months Ended 30 June 2014 7/18/2014
SAGE Therapeutics Announces Pricing Of Initial Public Offering 7/18/2014
Laboratory Corporation of America Holdings (LabCorp) (LH) Announces 2014 Second Quarter Results And Increases 2014 EPS Guidance 7/18/2014
Valeant Pharmaceuticals International (VRX) Files Investor Presentation 7/18/2014
Centene Corporation Completes Transaction With Spanish Health Management Group 7/18/2014
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014
West Pharmaceutical Services Announces 10% Increase In Quarterly Dividend 7/17/2014
Skystar Bio-Pharmaceutical (CGPN) Announces $5 Million Registered Direct Offering 7/17/2014
Esperion Therapeutics, Inc. (ESPR) To Host Inaugural Analyst And Investor Day 7/17/2014
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014
Celator Pharmaceuticals, Inc. Provides Update On CPX-351 And Technology Platform At Analyst Day 7/17/2014
Auspex Pharmaceuticals Announces Completion Of Follow On Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 7/17/2014
DIA Webinar With Veeva Systems, Inc. To Provide Insight On Improving Transparency And Collaboration With Regional Affiliates 7/16/2014
Cellular Biomedicine Group (CBMG) Raises $10 Million In Private Placement 7/16/2014
InSite Vision (ISV) To Webcast Annual Meeting Of Stockholders On July 16, 2014 7/16/2014
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014
Dipexium Pharmaceuticals (DPRX) To Ring The NASDAQ Stock Market Closing Bell 7/16/2014
Leading U.S. Proxy Advisory Firm Supports Teva Pharmaceutical Industries Limited (TEVA) Nominees And Other Shareholders’ Meeting Proposals 7/16/2014
BTG plc (BTG.L): Interim Management Statement And Annual General Meeting 7/16/2014
RestorGenex Announces Closing Of Its Private Placement Of Common Stock 7/15/2014
TNI BioTech Establishes New Record Date For Spin-Off Stock Dividend Of Cytocom, Inc. Shares 7/15/2014
Celsion Corporation (CLN) To Ring The NASDAQ Stock Market Closing Bell 7/15/2014
ErgoMed First Day Of Dealings On AIM 7/15/2014
StemCells Inc. (STEM) Announces Proposed $20 Million Offering 7/15/2014
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014
Helix Biopharma (CC:HBP) Announces Completion Of Private Placement 7/14/2014
Genocea Biosciences Commences Public Offering Of Common Stock 7/14/2014
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/14/2014
Maxygen, Inc. (MAXY) Announces Revised Record Date For Final Liquidating Distribution 7/14/2014
Mallinckrodt Pharmaceuticals (MNK) And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Provide Update On Transaction 7/14/2014
Sinovac Biotech Ltd. (SVA) Schedules 2014 Annual Meeting Of Shareholders 7/14/2014
Dicerna Pharmaceuticals (DRNA) To Ring The NASDAQ Stock Market Closing Bell 7/14/2014
Nuvilex (NVLX) Provides Shareholder Update On Milestone Accomplishments 7/14/2014
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million 7/11/2014
CannLabs Announces Ticker Symbol Change To CANL 7/11/2014
Applied DNA Sciences, Inc. (APDN) Announces Record Date For Annual Stockholders' Meeting 7/11/2014
Letter To NovaBay Pharmaceuticals, Inc. (NBY) Shareholders 7/11/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Exercise Of Greenshoe Option 7/11/2014
Thermo Fisher Scientific (TMO) Declares Quarterly Dividend 7/11/2014
Dicerna Pharmaceuticals (DRNA) To Ring The NASDAQ Stock Market Closing Bell July 15th 7/11/2014
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014
PuriCore: Trading Update and Strategic Review 7/11/2014
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014
Luye Pharma Trades Higher Following IPO In Hong Kong 7/10/2014
Ocera Therapeutics, Inc. (OCRX) Raises $25.2 Million In Public Offering 7/10/2014
Ocera Therapeutics, Inc. (OCRX) Announces Proposed Public Offering Of Common Stock 7/10/2014
TiGenix : Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 12 August 2014 7/10/2014
AbbVie (ABBV) Makes Fourth Bid For Shire, Hikes Bid To $51 Billion 7/9/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
Galectin Therapeutics Added To Russell 2000 Index 7/9/2014
Cantargia’s Share Issue Of 20 MSEK Fully Subscribed 7/9/2014
Seattle Genetics, Inc. (SGEN) To Host Conference Call And Webcast Discussion Of Second Quarter 2014 Financial Results On July 31, 2014 7/9/2014
Ultragenyx Pharmaceuticals (RARE) Announces Pricing Of Public Offering Of Common Stock 7/9/2014
Cardio3 BioSciences Announces Secondary Placement With New Institutional Investors 7/9/2014
Forbion Announces Closing Of Initial Public Offering Of Portfolio Company arGEN-X 7/9/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 7/9/2014
MabVax Therapeutics, Inc. Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants 7/9/2014
Verastem, Inc. (VSTM) To Ring The NASDAQ Stock Market Closing Bell 7/9/2014
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014
DelMar Pharmaceuticals Receives Funding From The Canadian Federal Government 7/9/2014
StemCells Inc. (STEM) Posts Letter To Shareholders 7/9/2014
GlobeImmune, Inc. (GBIM) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriter's Overallotment Option 7/9/2014
Charles River Laboratories (Massachusetts) Schedules Second-Quarter 2014 Earnings Release And Conference Call 7/8/2014
bluebird bio (BLUE) Announces Proposed Public Offering Of Common Stock 7/8/2014
Shire plc: Statement re: AbbVie (ABBV) Announcement 7/8/2014
Luminex Corporation (LMNX) Second Quarter Earnings Release Scheduled for July 28, 2014 7/8/2014
Ultragenyx Pharmaceuticals (RARE) Announces Proposed Public Offering Of Common Stock 7/8/2014
Urigen Pharmaceuticals, Inc. Announces Closing Of Restructuring, And Post-Close Addition Of New Board Member, And Restructuring Of Bridge Note 7/7/2014
Invitation To Lonza Group Ltd. (LZAGY.PK)’s Half Year Results 2014 Conference Call 7/7/2014
Highline Research Advisors Initiates On Titan Pharmaceuticals (TTP) With A Buy Rating 7/7/2014
Resverlogix Corporation (RVX.TO) Secures An Additional $30 Million From Citibank Loan 7/7/2014
Alcobra (ADHD) To Host Investor Forum And Webcast On July 15 In New York City 7/7/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 7/7/2014
Small But Tenacious: Two Of San Diego's Emerging Biotechs Sophiris Bio Inc. (SPHS) And Lpath, Inc. (LPTN) 7/3/2014
IGI Laboratories, Inc. Announces Closing Of Underwritten Offering Including Over-Allotment Option 7/3/2014
Oxford Finance and Solar Capital Close $30 Million Senior Debt Facility With Radius (RDUS) 7/2/2014
Actavis (ACT) Announces Final Stockholder Merger Consideration Election Results In Connection With Forest Laboratories, Inc. (FRX) Acquisition 7/2/2014
Vitrolife (VITR.ST) Release: Conference Call Interim Report 7/2/2014
Celator Pharmaceuticals, Inc. Announces Analyst Day and Webcast 7/2/2014
Achillion Pharmaceuticals, Inc. (ACHN) Added To The Russell 2000 And Russell Microcap Indexes 7/2/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
INSYS Therapeutics Reaffirms Second Quarter 2014 Revenue Guidance 7/1/2014
IsoRay, Inc. (ISR) Announces Its Addition To The Russell Microcap Index 7/1/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Joins Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes 7/1/2014
XOMA (US) LLC (XOMA) Call Today At 4:30pm ET/1:30pm PT To Confirm Communication Plan For EYEGUARD®-B Clinical Program 7/1/2014
TrovaGene, Inc. Secures $15 Million In Debt Financing From Trojantec Ltd. And Oxford Finance 7/1/2014
Relmada Therapeutics Files Shares Registration Statement 7/1/2014
Inovio Pharmaceuticals (INO) Added To Russell Global, Russell 2000® and Russell Microcap® Indexes 7/1/2014
Unilife Corporation (UNIS) Files To Renew Shelf Registration Statement 7/1/2014
Agile Therapeutics, Inc. Joins Russell Microcap® Index 7/1/2014
WaferGen Biosystems Announces Reverse Stock Split As It Pursues NASDAQ Listing 7/1/2014
Cardio3 BioSciences Announces Completion Of Its Capital Increase Of €25 Million At €44 Per Share 7/1/2014
TopoTarget A/S Release: New Articles Of Association Following Capital Increase 7/1/2014
TopoTarget A/S Release: Report Pursuant To The Danish Securities Trading Act, Section 28a 7/1/2014
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (30 June 2014) 7/1/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/1/2014
Mirati Therapeutics  (MRTX) Added To Russell 2000 Index 7/1/2014
Lipocine Inc. (LPCN) Added To Russell Microcap Index 6/30/2014
Enzo Biochem (ENZ) Added To Russell 2000 And Russell 3000 Indexes 6/30/2014
CytRx Corporation (CYTR) Added To Russell 3000® And Russell 2000® Indexes 6/30/2014
Akebia Therapeutics, Inc. (AKBA) Added To Russell 3000®, Russell 2000® And Russell Global Indexes 6/30/2014
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014
Change Of Number Of Shares And Votes In Moberg Pharma AB (Formerly known as Moberg Derma) 6/30/2014
Alnylam Pharmaceuticals (ALNY) Added To Russell 1000 Index As A Member Of The Large-Cap Segment Of The U.S. Equity Universe 6/30/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Closes Public Offering Of Common Shares 6/30/2014
iCo Therapeutics Inc. Announces Director Election Results From Its Annual Meeting of Shareholders 6/30/2014
NeuralStem Inc. Added To Russell 3000 Index 6/30/2014
La Jolla Pharmaceutical Company (LJPC) Added To The Russell Microcap Index 6/30/2014
Addex Therapeutics (ADXN.SW) Shareholders Approve All Board Proposals At Annual General Meeting 6/30/2014
Senomyx, Inc. (SNMX) Announces Inclusion In The Russell 2000® And Russell 3000® Indexes 6/30/2014
Alnylam Pharmaceuticals (ALNY) Added To Russell 1000 Index As A Member Of The Large-Cap Segment Of The U.S. Equity Universe 6/30/2014
Opexa Therapeutics (OPXA) Joins Russell Microcap Index 6/30/2014
Bio-Path Holdings, Inc. (BPTH) Added To Russell Global, Russell 3000® And Russell Microcap® Indexes 6/30/2014
Intra-Cellular Therapies, Inc. To Be Added To The Russell 3000® And Russell 2000® Indexes 6/30/2014
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014
Amphastar Pharmaceuticals, Inc. (AMPH) Announces Exercise of Over-Allotment Option 6/30/2014
Recro Pharma (REPH) Added To Russell Microcap® Index 6/30/2014
Karyopharm Therapeutics (KPTI) Announces Full Exercise Of Underwriters Option To Purchase Additional Shares In Public Offering Of Common Stock 6/30/2014
Aastrom Biosciences, Inc. (ASTM) Added To Russell Microcap Index 6/30/2014
Ohr Pharmaceutical (OHRP) Added To The Russell Indexes 6/30/2014
Big Investor Picks Up Large Stake In Allergan Inc. (AGN) To Push For Valeant Pharmaceuticals International (VRX) Merger 6/27/2014
IGI Laboratories, Inc. Announces Public Offering Of Common Stock 6/27/2014
Extraordinary General Meeting Held In Nordic Nanovector 6/27/2014
Monsanto Company (MON) Announces $4.5 Billion Debt Issue 6/27/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces Filing Of Annual Report On Form 20-F 6/27/2014
Idera Pharmaceuticals, Inc. (IDRA) To Be Added To The Russell 3000® And Russell 2000#0174; Indexes 6/27/2014
Palatin Technologies (PTN) To Join Russell Microcap Index 6/27/2014
BioSpecifics Technologies Corporation (BSTC) To Be Added To Russell 3000® Index 6/27/2014
United Therapeutics Corporation (UTHR) Announces Additional $500 Million Share Repurchase Program 6/27/2014
Alder Biopharmaceuticals Inc. Added to Russell 3000® Index 6/27/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Pricing Of $24 Million Underwritten Registered Direct Offering 6/27/2014
Celator Pharmaceuticals, Inc. To Be Added To Russell Microcap Index 6/27/2014
Karyopharm Therapeutics (KPTI) Announces Pricing Of Public Offering of Common Stock 6/27/2014
Karyopharm Therapeutics (KPTI) Announces Proposed Public Offering Of Common Stock 6/26/2014
Aldeyra Therapeutics (ALDX) To Join Russell Microcap Index 6/26/2014
Columbia Laboratories, Inc. (CBRX) Added To The Russell Microcap Index 6/26/2014
Ignyta (RXDX) To Be Added To Russell Microcap® Index 6/25/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Proposed Public Offering Of Common Shares 6/25/2014
Shire Release: PO Increased To 4500p. 6/25/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Prices $12.5 Million Public Offering Of Common Shares 6/25/2014
Baxter International, Inc. (BAX)’s Fifteenth Sustainability Report Highlights Commitment To Innovative Programs And Sustainable Design 6/25/2014
Aradigm Corporation (ARDM) To Host Corporate Update Conference Call On June 26 6/25/2014
Heron Therapeutics, Inc. (APPA) Announces Pricing Of Underwritten Offering Of Common Stock 6/25/2014



//-->